GE HealthCare Technologies (MEX:GEHC) ROCE % : 15.98% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is GE HealthCare Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GE HealthCare Technologies's annualized ROCE % for the quarter that ended in Dec. 2024 was 15.98%.

GE HealthCare Technologies ROCE % Historical Data

The historical data trend for GE HealthCare Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies ROCE % Chart

GE HealthCare Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

15.68

15.88

12.70

12.39

14.47

GE HealthCare Technologies Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial											12.10	10.98	12.69	13.39	15.98

GE HealthCare Technologies ROCE % Calculation

GE HealthCare Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	64360.69	/	( ( (550882.244 - 152445.721)	+	(690094.257 - 199234.502) )	/ 2 )
	=	64360.69	/	( (398436.523	+	490859.755)	/ 2 )
	=	64360.69	/	444648.139
	=	14.47 %

GE HealthCare Technologies's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	78834.544	/	( ( (666615.107 - 170714.901)	+	(690094.257 - 199234.502) )	/ 2 )
	=	78834.544	/	( ( 495900.206	+	490859.755 )	/ 2 )
	=	78834.544	/	493379.9805
	=	15.98 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

GE HealthCare Technologies (MEX:GEHC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

GE HealthCare Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

GE HealthCare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (MEX:GEHC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GEHC:USA L0T:Germany GEHC34:Brazil

Address

500 West Monroe Street, Chicago, IL, USA, 60661

Website

https://www.gehealthcare.com

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).